Haemonetics (HAE) Change in Accured Expenses (2009 - 2026)

Haemonetics has reported Change in Accured Expenses for 18 years, with the latest figure at -$12.6 million in Q2 2026.

• On a quarterly basis, Change in Accured Expenses rose 73.66% year-over-year to -$12.6 million in Q2 2026; TTM through Jun 2026 was $18.7 million, a 181.35% increase from a year earlier, with the FY2026 full-year figure at -$16.6 million, up 13.73% from the prior year.
• Change in Accured Expenses was -$12.6 million for Q2 2026 at Haemonetics, down from $20.3 million in the prior quarter.
• The five-year high for Change in Accured Expenses was $49.5 million in Q1 2024, with the low at -$47.9 million in Q2 2025.
• Average Change in Accured Expenses over 5 years is $3.6 million, with a median of $6.1 million recorded in 2022.
• The sharpest annual moves came in 2022 and 2023: Change in Accured Expenses jumped 836.31% in 2022, then plunged 424.4% in 2023.
• Over 5 years, Change in Accured Expenses stood at $7.3 million in 2022, then slumped by 424.4% to -$23.7 million in 2023, then jumped by 113.96% to $3.3 million in 2024, then tumbled by 302.36% to -$6.7 million in 2025, then tumbled by 88.4% to -$12.6 million in 2026.
• The last three Change in Accured Expenses figures came in at -$12.6 million (Q2 2026), $20.3 million (Q1 2026), and -$6.7 million (Q4 2025), per Business Quant data.